Search research articles
Contact Us
Filters
Showing results (111-120 of 149) with videos related to
Page
of 15
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
November 5, 2003
Essential role for RGS9 in opiate action
Venetia Zachariou, Dan Georgescu, Nick Sanchez, et al.
Molecular and Cellular Biology
|
August 18, 2004
Mice with deficiency of G protein gamma3 are lean and have seizures
William F Schwindinger, Kathryn E Giger, Kelly S Betz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 2, 2010
FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration
Katherine W Falenski, Andrew J Thorpe, Joel E Schlosburg, et al.
Journal of Medicinal Chemistry
|
December 29, 2023
Molecular Pharmacology Profiling of Phenylfentanil and Its Analogues to Understand the Putative Involvement of an Adrenergic Mechanism in Fentanyl-Induced Respiratory Depression
Mengchu Li, Piyusha P Pagare, Hongguang Ma, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 17, 2016
Discriminative Stimulus Properties of the Endocannabinoid Catabolic Enzyme Inhibitor SA-57 in Mice
Robert A Owens, Bogna Ignatowska-Jankowska, Mohammed Mustafa, et al.
Neuropharmacology
|
September 20, 2024
Dissociation between the anti-allodynic effects of fingolimod (FTY720) and desensitization of S1P<sub>1</sub> receptor-mediated G-protein activation in a mouse model of sciatic nerve injury
Abby M Pondelick, Lauren V Moncayo, Giulia Donvito, et al.
Journal of Medicinal Chemistry
|
January 5, 2019
Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands
Yi Zheng, Samuel Obeng, Huiqun Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 23, 2014
Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice
Joel E Schlosburg, Steven G Kinsey, Bogna Ignatowska-Jankowska, et al.
Journal of Neurochemistry
|
June 5, 2009
Sphingosine-1-phosphate receptors mediate neuromodulatory functions in the CNS
Laura J Sim-Selley, Paulette B Goforth, Mba U Mba, et al.
European Journal of Pharmacology
|
November 20, 2019
Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorder
Yi Zheng, Samuel Obeng, Bethany A Reinecke, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 149) with videos related to
Sort By:
Page
of 15
Proceedings of the National Academy of Sciences of the United States of America
|
November 5, 2003
Essential role for RGS9 in opiate action
Venetia Zachariou, Dan Georgescu, Nick Sanchez, et al.
Molecular and Cellular Biology
|
August 18, 2004
Mice with deficiency of G protein gamma3 are lean and have seizures
William F Schwindinger, Kathryn E Giger, Kelly S Betz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 2, 2010
FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration
Katherine W Falenski, Andrew J Thorpe, Joel E Schlosburg, et al.
Journal of Medicinal Chemistry
|
December 29, 2023
Molecular Pharmacology Profiling of Phenylfentanil and Its Analogues to Understand the Putative Involvement of an Adrenergic Mechanism in Fentanyl-Induced Respiratory Depression
Mengchu Li, Piyusha P Pagare, Hongguang Ma, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 17, 2016
Discriminative Stimulus Properties of the Endocannabinoid Catabolic Enzyme Inhibitor SA-57 in Mice
Robert A Owens, Bogna Ignatowska-Jankowska, Mohammed Mustafa, et al.
Neuropharmacology
|
September 20, 2024
Dissociation between the anti-allodynic effects of fingolimod (FTY720) and desensitization of S1P<sub>1</sub> receptor-mediated G-protein activation in a mouse model of sciatic nerve injury
Abby M Pondelick, Lauren V Moncayo, Giulia Donvito, et al.
Journal of Medicinal Chemistry
|
January 5, 2019
Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands
Yi Zheng, Samuel Obeng, Huiqun Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 23, 2014
Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice
Joel E Schlosburg, Steven G Kinsey, Bogna Ignatowska-Jankowska, et al.
Journal of Neurochemistry
|
June 5, 2009
Sphingosine-1-phosphate receptors mediate neuromodulatory functions in the CNS
Laura J Sim-Selley, Paulette B Goforth, Mba U Mba, et al.
European Journal of Pharmacology
|
November 20, 2019
Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorder
Yi Zheng, Samuel Obeng, Bethany A Reinecke, et al.
Page
of 15